Myung In Pharmaceutical LTD. (KRX:317450)
South Korea · Delayed Price · Currency is KRW 67,500
-1,800 (-2.60%)
At close: Nov 25, 2025
KRX:317450 Revenue
Myung In Pharmaceutical LTD. had revenue of 72.70B KRW in the quarter ending September 30, 2025, with 10.75% growth. This brings the company's revenue in the last twelve months to 283.31B. In the year 2024, Myung In Pharmaceutical LTD. had annual revenue of 269.43B with 11.18% growth.
Revenue (ttm)
283.31B
Revenue Growth
+11.18%
P/S Ratio
3.79
Revenue / Employee
845.69M
Employees
335
Market Cap
1.07T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 269.43B | 27.10B | 11.18% |
| Dec 31, 2023 | 242.34B | 16.51B | 7.31% |
| Dec 31, 2022 | 225.83B | 16.58B | 7.92% |
| Dec 31, 2021 | 209.25B | 21.41B | 11.40% |
| Dec 31, 2020 | 187.84B | 6.05B | 3.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| Hyundai Motor Company | 186.04T |
| Kia Corporation | 113.20T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Hanwha Aerospace | 23.11T |
| Doosan Enerbility | 16.79T |
| HD Hyundai Heavy Industries | 16.39T |